Clinical trial
COMParison of the EffecT of mEdication Therapy: Anticoagulation Versus Anti-platelet Versus Migraine Therapy in Alleviating Migraine With Patent Foramen Ovale
NCT05546320 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences, Fuwai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COMParison of the EffecT of mEdication Therapy: Anticoagulation Versus Anti-platelet Versus Migraine Therapy in Alleviating Migraine With Patent Foramen Ovale
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 15, 2022
- Completion date
- March 26, 2025
- Enrollment
- 1,000 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.
migraine, patent foramen ovale